Justine Badée

Justine Badée

Auto-generated profile, based on publicly available information

Justine Badée

Pharmacokinetic Sciences, Novartis Biomedical Research, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2025 in CPT: Pharmacometrics & Systems Pharmacology
Verified
Journal Article
Open access
JMJulia Macente
Julia Macente
Nina NauwelaertsNina Nauwelaerts
Nina Nauwelaerts
JBJustine Marine Badée
Justine Marine Badée
Rodolfo Hernandes BonanRodolfo Hernandes Bonan
Rodolfo Hernandes Bonan
MHMiao‐Chan Huang
Miao‐Chan Huang
PAPieter Annaert
Pieter Annaert
Physiologically‐based pharmacokinetic (PBPK) modeling can support decision‐making on maternal medication use during breastfeeding. This study aimed to enhance lactation PBPK models in two ways. First, the utility of integrating permeability‐ versus perfusion‐limited distribution to human milk was explored using the Simcyp Simulator. Secondly, for permeability‐limited models, drug‐specific bidirectional intrinsic clearance across the blood‐milk barrier, predicted from drug physicochemical properties, was incorporated into lactation PBPK models. Initially, reference PBPK models were developed and verified against published clinical data. Geometric Mean Fold Error (GMFE; ~accuracy) and Average Fold Error (AFE; ~bias) for these models ranged from 1.13–1.51 and 0.68–1.42, respectively. These verified models were then extended to lactation PBPK models applying either permeability‐ or perfusion‐limited assumptions for drug distribution across the blood‐milk barrier. The lactation PBPK models were applied to predict drug concentrations in human milk and relative infant doses (RID) for 11 small molecule drugs with diverse physicochemical and disposition profiles. The models successfully predicted observed plasma PK, human milk concentration‐time profiles, and milk‐to‐plasma ratios. Nine drugs had RID values below the safety threshold of 25%, while levetiracetam and nevirapine showed relatively higher RIDs (up to 21%). Based on these findings, a decision tree is proposed to guide the selection between permeability‐ or perfusion‐limited distribution models in future lactation PBPK applications using Simcyp. This workflow can be extended beyond the 11 model drugs evaluated, supporting broader infant risk assessment for maternal medication during lactation.

2 July 2025 in Drug Metabolism and Disposition
Verified
Journal Article
Closed access
BJBadée Justine
Badée Justine
GHGu Helen
Gu Helen
FHFelix Huth
Felix Huth
PBPoller Birk
Poller Birk
HSHilmar Schiller
Hilmar Schiller
EHEinolf J. Heidi
Einolf J. Heidi

12 December 2025 in Drug Metabolism and Pharmacokinetics
Verified
Journal Article
Closed access
KUKenichi Umehara
Kenichi Umehara
AHAndrew Harrell
Andrew Harrell
CPChandra Prakash
Chandra Prakash
CHConstanze Hilgendorf
Constanze Hilgendorf
TBT. Eric Ballard
T. Eric Ballard
YCYuan Chen
Yuan Chen

3 July 2026 in Drug Metabolism and Disposition
Verified
Journal Article
Closed access
LMLina Mettler
Lina Mettler
JBJustine Badée
Justine Badée
FHFelix Huth
Felix Huth
CLChristian Lohasz
Christian Lohasz
JAJohanna Alm
Johanna Alm
JRJulia Riede
Julia Riede